安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Article - Billing and Coding: MolDx: BCR-ABL (A55233)
CPT codes 81206, 81207, and 81208 may only be reported when performed as a single test To submit a claim for BCR-ABL translocation analysis by NGS, use CPT 81479 and one (1) UOS with the assigned DEX Z-code
- CPT® Code 81207 - Genetic Analysis Procedures - Codify by AAPC
The Current Procedural Terminology (CPT ®) code 81207 as maintained by American Medical Association, is a medical procedural code under the range - Genetic Analysis Procedures
- Presentation - Quest Diagnostics
CPT Codes 81206, 81207, and 81208 BCR ABL is considered medically necessary in the evaluation of individuals with chronic myelogenous leukemia or BCR-ABL positive acute lymphoblastic leukemia to evaluate treated individuals who manifest suboptimal response to initial tyrosine kinase inhibitor therapy or loss of response to tyrosine kinase
- What is CPT Code 81207: A Deep Dive into BCR ABL1 Translocation . . .
CPT code 81207 inherently includes both qualitative and quantitative analyses, meaning this additional instruction does not require a different code but a precise understanding of the code’s applicability
- Procedure Codes 81206 and 81207 Open for Billing
Effective November 1, 2024, procedure codes 81206 (BCR ABL1 Gene Major BP) and 81207 (BCR ABL1 Gene Minor BP) may be billed by provider type 43 (Laboratory, Pathology Clinical)
- CPT® Code 81207 in section: BCR ABL1 (t (9;22))
81207 - CPT® Code in category: BCR ABL1 (t (9;22)) CPT Code information is available to subscribers and includes the CPT code number, short description, long description, guidelines and more CPT code information is copyright by the AMA
- Medicare Local Coverage Determination Policy
This policy provides coverage for multi-gene non-next generation sequencing (NGS) panel testing and NGS testing for the diagnostic workup for myeloproliferative disease (MPD), also known as myeloproliferative neoplasms (MPNs), and limited coverage for single-gene testing of patients with BCR-ABL negative MPD
- 2025 Medicare - clinicallabs. com
Coverage Policy L36180: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease CPT: 81206, 81207, 81208, 81219, 81270, 81279, 81339, 81450, 81479, 0027U, 0040U
|
|
|